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The pyridoxal-50-phosphate-binding domain (PLPbd) of bsSHMT (Bacillus subtilis
serine hydroxymethyltransferase) was cloned and over-expressed in Escherichia coli.
The recombinant protein was solublized, refolded and purified from inclusion bodies
by rapid mixing followed by ion exchange chromatography. Structural and func-
tional studies suggested the native form of the domain, which obtained as a monomer
and had similar secondary and tertiary structural properties as when present in the
bsSHMT. The domain also binds to the PLP however with slightly lesser affinity than
the native enzyme. GdmCl (guanidium chloride)-induced equilibrium unfolding of
the recombinant PLP-binding domain showed a single monophasic transition which
corresponds with the second phase transition of the GdmCl-induced unfolding of
bsSHMT. The results indicate that PLPbd of bsSHMT is an independent domain,
which attains its tertiary structure before the dimerization of partially folded mono-
mer and behaves as a single cooperative unfolding unit under equilibrium
conditions.
Key words: autonomous folding domain, conserved domain, PLP-binding domain,
refolding and serine hydroxymethyltransferase.
Abbreviations: bsSHMT, Bacillus subtilis SHMT; CD, circular dichroism; eSHMT, E. coli SHMT; GdmCl,
guanidium chloride; PLP, pyridoxal-50-phosphate; SEC, size-exclusion chromatography; SHMT, serine
hydroxymethyltransferase and for amino acids single-letter abbreviations have used.
Given the kinetic competition between folding and pro-
teolytic degradation of the nascent polypeptide chain,
evolution has found two ways to escape this paradox.
First by funnelling the polypeptide through folding path-
ways (1–3) and second, by independent folding by parts
of separate domains, supporting multiple nucleation sites
and sequential (co-translational) structure formation
(4, 5). The latter mechanism is based on the concept
that large polypeptide chains consist of domains as stable
folding units. Domains represent substructures with
specific functional properties with well-defined binding
properties for ligands such as substrates, co-enzymes,
etc. with the active site of enzyme often being positioned
between domains (6). However, there is no unequivocal
theoretical approach for identifying the boundaries of
domains.
Recombinant DNA technology is an alternative and
more versatile approach for probing the boundaries of
putative structural domains. By using the known struc-
ture of the protein as a guide, the separation of protein
fragments can be performed at the level of the gene,
independent of whether the putative connectors are at
the surface of the protein or not. This approach can
overcome the truncation of the proteins, by expressing
the isolated domains in larger and homogenous amounts
in transformed microorganisms (7).
Serine hydroxymethyltransferase (SHMT) is a cata-
bolic enzyme that catalyses the removal of one-carbon
fragments for the production of nucleotides, methionine,
thymidylate, choline and other organic molecules. SHMT
also provides glycine for the cell, which through addi-
tional processing becomes pyruvate, the core energy
molecule for organisms. This process allows microbial
cells to convert amino acids, a common carbon substrate
in their environment, to simple sugars as a secondary
energy source (8). Pyridoxal-50-phosphate (PLP) is a
versatile co-factor able to catalyse a spectrum of
reactions on a variety of amino acid substrates.
Goldsmith and colleagues (9) classified PLP-dependent
enzymes into five different fold types on the basis of
amino acid sequence comparison, predicted secondary
structural elements and available three-dimensional
structure. SHMT belongs to the type I fold or aspartate
aminotransferase family of proteins that is the largest,
most diverse, best structurally characterized and found
in two different evolutionary lineages, providing exam-
ples of convergent enzyme evolution (10). These proteins,
though genetically dissimilar, have matching secondary
and tertiary structures between the subunits of different
species (11). The final protein complex of the prokaryotes
and eukaryotes also differs, with the prokaryotes tending
to form tight dimers, whereas the eukaryotes form
tetramers (12).
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Each subunit of bsSHMT folds into two domains;
a large PLP-binding domain and a small C-terminal
domain. The N- and C-terminal parts of the chain do not
have a common fold within this class. However, the
central and largest part that forms a/b barrel domain
binds the co-factor PLP. All the PLP-dependent enzymes
are predicted to possess an a/b barrel motif for binding
the co-factor. Hence, this domain is the most conserved
part and has the same fold in entire family, even though
some members of the family are least similar in amino
acid sequence (13–16). The large PLP-binding domain
comprises of 214 amino acid residues starting from 63 to
276 (numberings as for Bacillus stearothermophilus
serine hydroxymethyltransferase, bstSHMT; PDB id,
1KKJ) and includes all side chains that are important
for the binding of PLP (13).
There are a few reports about the independent PLP-
binding domain of Escherichia coli aspartate amino-
transferase and role of PLP in the folding of SHMT
(17, 18) but, not much have been reported about the role
of PLP-binding domain in the folding and stability of
SHMT. Moreover, the native bsSHMT appears to follow
a three-state unfolding transition involving a compact
intermediate (14). The availability of pure, homogenous
independent domain would allow the characterization of
intermediate state and will help in assessment of the
independent folding capability of co-factor-binding
domain of bsSHMT.
In the present study, the recombinant PLP-binding
domain of bsSHMT was produced based solely on the
structural boundaries of the domain. We report on the
cloning, over-expression, refolding, purification, biochem-
ical as well as structural characterization of the recombi-
nant PLP-binding domain. Structural changes associated
with temperature and GdmCl-induced unfolding of the
domain was studied and compared to those of native
bsSHMT.
EXPERIMENTAL PROCEDURES
Construction of PLP-Binding Domain Expressing
Plasmid—The 650 bp gene encoding 214 aa (G63–
D276)-long PLP-binding domain was PCR (polymerase
chain reaction) amplified from the full-length gene of
bsSHMT (pET21d-bsSHMT) using the following primers:
sense primer, 50-CGCGGATCCGGATGTGAGCACGTCG
ACGTC-30 and anti-sense primer, 50-GGGGTACCCTAGT
CCTGCAATACTTCACCGAATGA-30, containing BamH1
and Kpn1 restriction sites (underlined nucleotides) at 5
and 30, respectively. The PCR reaction was carried out
for 30 cycles in a total volume of 50 ml with 1 U of Taq
polymerase and thermocycler condition used was 958C,
1 min denaturation; 578C, 1 min annealing; 728C, 2 min
amplification, respectively. The fragment was cloned into
vector (pQE30) between BamHI and KpnI sites and the
DNA sequence was confirmed by sequencing. The
obtained plasmid (pQE30plpbd) was introduced into
E. coli BL21 (DE3) cells for protein expression and was
induced at OD600 of 0.6 by adding a final concentration of
0.5 mM IPTG (isopropyl b-D thiogalactopyranoside). The
cells were further grown for 3 h at 378C before harvest-
ing. The cell pellet was re-suspended in 50 mM Tris
buffer pH 7.4 containing 1 mM EDTA and 2 mM
b-mercaptoethanol and stored at –808C for further use.
Isolation, Solubilization and Refolding of Recombinant
PLPbd Inclusion Bodies—The frozen cell pellets were
freeze-thawed (thrice) and after a mild sonication cell
lysate was centrifuged at 24,000 g for 15 min. Pellet was
washed with distilled water twice to remove salts. The
final sediment containing inclusion bodies was used for
solubilization. Inclusion bodies were solubilized (1 mg/ml)
in 50 mM potassium phosphate buffer pH 7.4 containing
6 M urea, and 0.5 M NaCl for 1 h at 48C and centrifuged
for 30 min at 24,000 g. Five millilitres of supernatant
containing the solubilized domain was added drop by
drop to 100 ml of stirring potassium phosphate buffer
(50 mM, pH 7.4 containing 1 mM EDTA, 2 mM
b-mercaptoethanol, 0.1 mM PLP and 0.1 M NaCl). This
refolded protein solution was centrifuged at 24,000 g for
30 min and the supernatant was dialysed against the
potassium phosphate buffer (50 mM, pH 7.4 containing
1 mM EDTA and 2 mM b-mercaptoethanol) with three
changes of buffer.
Purification of Recombinant PLP-Binding Domain—
After dialysis the refolded mixture, which had only 10%
protein contaminants was loaded on MonoQ column (GE
Healthcare, Sweden) equilibrated with the same buffer
(50 mM, pH 7.4 containing 1 mM EDTA and 2 mM
b-mercaptoethanol). The protein was eluted as a linear
gradient with final buffer containing 1 M NaCl.
The purity of the obtained protein was checked using
SDS–PAGE and was found to be >98% pure. The
yield by mass of refolded protein from a pellet was
found 20–25%.
CD (Circular Dichroism) Measurements—CD measure-
ments were made with a Jasco J810 spectropolarimeter
calibrated with ammonium (+)-10-camphorsulphonate.
The results are expressed as relative ellipticity and
plotted as percentage values. The CD spectra were
measured at an enzyme concentration of 3 and 15 mM
for far- and near-UV or visible CD measurements,
respectively. Far- and near-UV measurements were
made in 2 and 10-mm path length quartz cell, respec-
tively at 258C. The values obtained were normalized by
subtracting the baseline recorded for the buffer having
same concentration of denaturant under similar condi-
tions. Thermal denaturation experiments were per-
formed by increasing the temperature from 20 to 958C.
The observed ellipticities at 222 nm were recorded
against the increasing temperature.
Synthesis of PyP-SHMT—The reduction of PLP aldi-
mine was achieved according to the procedure of Cai and
Schirch (19). In brief, cells were dialysed with 0.1%
NaCNBH3 in 50 mM phosphate buffer, pH 7.4 containing
1 mM EDTA and 2 mM b-mercaptoethanol for 12 h.
Further, excess NaCNBH3 was removed by dialysing
the protein against same buffer for 24 h.
Limited Proteolysis—The native and 1 M GdmCl-
treated samples were subjected to limited proteolysis
with a-chymotrypsin. The protein (1 mg/ml) was incu-
bated in presence and absence of GdmCl for 4 h at 48C
before adding the a-chymotrypsin (protease: protein ratio
of 1:100). Proteolysis was carried out for 5 min at same
temperature in a 100ml reaction volume. Reaction was
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stopped with 2 mM PMSF and the mixture was analysed
on 12% SDS–PAGE.
Size-Exclusion Chromatography—Gel filtration experi-
ments were carried out on Superdex 200HR 10/30 column
(exclusion limit 600 kDa for proteins) on AKTA FPLC
(GE Healthcare, Sweden), pre-equilibrated and run with
phosphate buffer (50 mM, pH 7.2 containing 1 mM EDTA,
2 mM b-mercaptoethanol and 150 mM NaCl). The protein
sample 200ml was loaded on the column and run at 25uC
with the flow rate of 0.3 ml/min and continuous detection
at 280 nm. The apparent molecular masses and Stoke’s
radii of the proteins were determined from the calibration
curves for proteins of known molecular mass and Stoke’s
radius (BSA, 66.3 kDa; 33.9 A8; ovalbumin, 43.5 kDa;
31.2 A8; myoglobin, 16.9 kDa; 20.2 A8 and cytochrome c,
11.7 kDa; 17.0 A8).
RESULTS AND DISCUSSION
The PLP-binding domain in isolation retains the fold
pattern and symmetry compared to the native bsSHMT
(Fig. 1; PDB id, 1KKJ). We report first time the
characterization of an isolated co-factor-binding domain
of any SHMT.
Refolding of Inclusion Bodies—The over-expression of
recombinant proteins in the reducing environment of
E. coli cytosol frequently leads to intra-cellular accumula-
tion of its aggregated form (20). Mostly the solublization
of these insoluble aggregates followed by the removal of
effective concentration of denaturant is necessary for
refolding and in obtaining the soluble and active form of
the protein. We refolded the inclusion bodies into soluble
native form and purified (98%) efficiently (Fig. 2).
The refolding of the inclusion bodies was observed by
monitoring the change in far-UV CD-spectra for second-
ary structure. Figure 3A shows the spectra of inclusion
bodies solublized in 6.0 M urea as well as those of 20
times diluted and refolded protein sample. The CD
spectra of diluted fraction of proteins suggest that the
refolded domain has significant amount of secondary
structure. Refolding of the solubilized inclusion bodies of
the isolated domain was also examined on size-exclusion
column by monitoring the hydrodynamic radii of the
refolded fragment. The inclusion bodies were solubilized
in 6.0 M urea containing buffer and then the fraction was
diluted twenty times, centrifuged at 24,000 g for 10 min.
Supernatant, with protein concentration 0.2 mg/ml was
loaded on the Superdex S-200 column, equilibrated with
phosphate buffer without urea, in the presence and
absence of co-factor PLP, it was eluted as a single peak
without any visible aggregates in the chromatogram
(Fig. 3B, and inset). The elution volume, compared with
standard protein elution profile, suggests that the
refolded protein has 25 kDa molecular weight which is
similar to the theoretical molecular weight of the
domain; hence it suggests that the fragment folded suc-
cessfully on dilution in the column. Under similar
conditions, in the presence of PLP which was monitored
at 425 nm together with A280 nm the protein was eluted
again at the same retention volume with another peak,
which denote the absorbance of PLP together with the
protein (Fig. 3B and inset). Elution of refolded domain at
the same retention volume in the presence and absence
of PLP shows that the co-factor does not play any role in
the folding of PLP-binding domain, which is in line with
earlier observation on eSHMT (E. coli SHMT) (21).
Binding of the co-factor PLP to the domain also suggests
that the refolded domain attains its native fold during
refolding from inclusion bodies. The results presented
above indicate clearly that the fragment over-expressed
represents the independent folding domain and its
efficient refolding may be due to the high stability of
this PLP-binding domain. The over-expressed protein
have formed inclusion bodies inside the bacterial cell
probably, because of high concentration of over-expressed
protein and some exposed hydrophobic patches that would
have masked by the other domain in the native molecule.
A B
Fig. 1. The picture is showing the bsSHMT. (A) and the
isolated PLP-binding domain (B). In the fig. A, N-terminal and
C-terminal portion is shown in light grey colour and co-factor-
binding domain is in black colour. Figure B is the isolated part of
bsSHMT from residue G63 to D276. The pictures were produced
in program ‘SPDBV’ by using bstSHMT crystal structure as
template (PDB id, 1KKJ) (13).
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The successful refolding of independent domain indi-
cates that this method of refolding is useful for obtaining
the recombinant isolated domains in soluble form and
can be proven a great approach in deciphering the
functional and structural roles of individual domains in
multi-domain proteins.
Structural Characterization of Isolated Domain—One
of the serious problems in interpreting the data obtained
with protein fragments is that the ‘nativeness’ of the
fragments is always doubtful. Even if the fragments are
shown to be fully compact and globular there is no
guarantee that they will behave in exactly the same way,
as they would have done when they were part of the
intact protein molecule. This made us to look for the
structural characterization, which will be helpful in
drawing any conclusion about the nativeness of the
refolded recombinant domain.
The effect of the removal of N- and C-terminal extensions
from the molecule was observed on the secondary and
tertiary structure of the PLP-binding domain.
Secondary Structural Characterization by Far-UV CD
Spectroscopy—The far ultraviolet CD spectra for the
recombinant domain were examined to obtain the
information on the conformation of the recombinant
domain’s polypeptide backbone. Figure 4A summarizes
the comparison between the secondary structure of the
isolated domain and wild-type bsSHMT. For the
bsSHMT, far-UV CD spectrum with a positive ellipticity
maximum at 193 nm and negative ellipticity maxima at
208 and 222 nm, typical of proteins with high a-helical
content was observed. The homology model of the domain
suggests that the isolated domain folds into a aba
structure consisting of eight-stranded b-sheet flanked
by a-helices on both sides (Fig. 1B). Secondary structural
analysis from the bsSHMT model suggests that the
domain has almost 40% of its secondary structure as
a-helix. The observed spectra showed maxima at 196 nm,
minima at 209 nm and broad minima centred at 220 nm,
which is similar to those for proteins with mixed type of
secondary structures. This implies that the recombinant
domain has similar secondary structural component as
predicted by the homology model of the native protein
bsSHMT and have folded conformation.
Tertiary Structural Characterization by Near-UV CD
Spectroscopy—The tertiary structural information of
isolated domain was also obtained using CD spectro-
scopy. Figure 4B represents comparison of the near-UV
and visible CD spectra of the bsSHMT and recombinant
PLP-binding domain. For both bsSHMT and isolated
domain, strong near-UV and visible CD signal were
observed suggesting the presence of buried tyrosine
residues and bound PLP in the proteins (22, 23). The
existence of peak in near-UV region indicates that some
or most of the tyrosine residues of recombinant PLP-
binding domain are buried in specific and tightly packed
environments and it was proposed that maxima at
275 nm can serve as markers for the native fold (24).
Furthermore, compared to the wild-type proteins, the
polarization spectra of holo domain gave little blue shift
in visible CD signal. This shift in the spectra is probably
because of the relatively free orientation of the PLP
molecule in the domain whereas, in the wild-type
bsSHMT, PLP is bound to both domain and dimer inter-
face and cannot rotate freely. The ellipticity change of
recombinant holodomain in near-UV CD, due to buried
tyrosine residues suggests an asymmetric environment of
24 kDa
45 kDa
1 2 3 4 5 6
Fig. 2. The gel photograph is showing molecular weight
markers (lane 1). Lanes 2–4 is showing pellet of cell lysate
having protein as inclusion bodies, supernatant of cell lysate
and inclusion bodies solubilized in 6 M urea, respectively. Lanes
5 and 6 are representing refolded and purified soluble domain,
respectively.
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Fig. 3. Refolding of inclusion bodies. (A) The Far-UV CD
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(curve 2). The chromatograms are showing refolding of inclusion
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the chromophore that is similar to the native bsSHMT.
The differences observed in the secondary structure
content could be due to variable amounts of structures
present between the native enzyme and the isolated
domain.
Characterization of Oligomeric State—The oligomeric
state of recombinant domain in solution was investi-
gated on size-exclusion chromatography. Gel filtration
chromatogram (Fig. 4C) of the refolded isolated fragment
represents the elution profile. The apparent molecular
mass of the peak was estimated to be 25 kDa. This
information suggests that the domain is monomeric even
at the concentration of 1 mg/ml (40 mM) and at this
concentration protein was not showing any aggregation
on storage up to 1 month.
Functional Characterization—SHMT (EC 2.1.2.1)
contains covalently bound pyridoxal-P, which forms an
internal aldimine with the 2-amino group of lysine. This
enzyme is a member of the a-class of pyridoxal-50-
phosphate enzymes, catalyses the reversible interconver-
sion of serine and tetrahydrofolate (THF) to glycine and
5, 10 methylene tetrahydrofolate, changing the chemical
bonding at the Ca–Cb bond of the serine side chain,
mediated by the pyridoxal phosphate cofactor with the
help of another coenzyme H4-folate (25).
The specific binding of PLP can be detected by UV-
visible absorption spectroscopy. The protein bound PLP
gives absorption maxima at 340 and 425 nm, which are
generally ascribed to enolimine and ketoenamine tauto-
mers, respectively, of the Schiff base formed between
PLP and a lysine residue of the protein. But in most
PLP-binding proteins, the ketoenamine form that
absorbs at around 425 nm dominates (17, 26). The
co-enzyme PLP itself can bind covalently and form
external aldimine complex with glycine and a marked
and rapid increase in the intensity of the yellow colour of
the solution together with the increase in absorption can
be observed. This increase and red shift in absorbance is
because of the Schiff’s base formation between free PLP
and glycine (25).
Since, the residues which constitute the active site in
the native enzyme not only come from different parts of
the polypeptide chain but also from other polypeptide
chain (B chain) of dimer, it was expected that the
isolated co-factor-binding domain would not be active,
although it binds PLP. All the residues those are
responsible for the binding of co-factor PLP lie between
G63 and D276 of the domain, except Y51 and G257
(B chain), which come from the other chain of the dimer
in the native molecule. The numberings are according to
the crystal structure of bstSHMT (13) which have strong
homology and identity 96 and 86%, respectively in this
region. The presence of most of the PLP-binding residues
in the domain ensures that the co-factor PLP can bind to
the molecule. And the binding of the co-factor to the
recombinant PLP-binding domain was further verified by
the strong absorption of domain bound PLP at 425 nm in
absorption spectra of the holodomain (curve 2 in Fig. 5A),
the spectrum of the holodomain solution was subtracted
by that of the free PLP. The apo-form of the domain,
which was obtained by incubating the holodomain with
10 mM hydroxylamine in phosphate buffer was further
incubated with 2 mM PLP per 1 mM of the domain and
then was dialysed against the buffer to remove unbound
and excess PLP. The proper binding of PLP to the
recombinant domain guaranteed by the absorption of
holodomain at 425 nm, like the native molecule; suggests
that the domain is in native and functional conformation.
As discussed above, holodomain can also bind the amino
acid glycine through PLP, which is also the substrate for
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Fig. 4. Structural characterization of recombinant
PLPbd. (A) Far-UV CD spectra of, the recombinant isolated
domain (spectrum 1) and dimeric bsSHMT (spectrum 2).
(B) Near- and Visible-CD spectra of recombinant PLP-binding
domain (spectrum 1) and dimeric bsSHMT (spectrum 2). (C) The
chromatogram is showing the elution profile of refolded and
purified recombinant PLP-binding domain of bsSHMT. The
number on peak is showing the retention volume.
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the enzyme SHMT and most of the residues which bind
the substrate glycine are present in this isolated PLPbd
(13). Hence, the holodomain was incubated with 50 mM
glycine and spectra were recorded between 550 and
380 nm (Fig. 5A). The curve 3 represents the enhanced
intensity of absorption of the complex of holodomain with
glycine. Since, the free PLP present in the solution can
also form the complex with the excess of glycine in the
reaction buffer; the spectrum was subtracted with equi-
molar free PLP and glycine complex and presented as
curve 4. The red shift (Fig. 5A, curve 4) in the absorption
of the bound PLP indicates that the domain bound PLP
molecule formed complex with the substrate glycine (25).
The holodomain was reduced with sodium cyanobor-
ohydride (NaCNBH3) to determine weather PLP is bound
covalently as a Schiff’s base. As expected, the absorbance
maximum at 425 nm was shown blue shift in reduced
protein as a single and relatively broader peak at around
355 nm (Fig. 5B), which is characteristic of 2-(phospho-
pyridoxyl) lysine (17). This result showed that borohy-
dride reduced the aldimine linkage to yield the aldamine
bond that usually absorbs in the range of 325–340 nm in
PLP-binding enzymes but broader absorbance of pyridox-
amine-50-phosphate (reduced aldimine) with peak cen-
tered around 355 nm is close to the typical values for
the deprotonated Schiff base (360–380 nm); whereas, the
deprotonated Schiff base should not be formed under the
described condition. Deprotonation of Schiff base usually
occurs because of the movement of the aldimine from
hydrophobic environment to less hydrophobic environment
(27). And this could be possible because of the relatively
free orientation of the PLP molecule in the domain.
The absorption spectra of holodomain and its complex
formation with glycine shows that the molecule is in its
native fold and these results together with secondary and
tertiary structural characterization (Figs 4 and 5) of the
isolated and refolded domain indicate that the PLP-
binding domain is autonomous and independent folding
domain.
Temperature Denaturation of the Isolated Domain—
The thermo-stability of recombinant PLP-binding domain
was examined based on the residues molar ellipticity
of the polypeptide chain at increasing temperatures. In
the far-UV region, the CD spectrum of native isolated
domain and bsSHMT both shows the presence of
substantial amount of ellipticity at 222 nm. Hence, loss
of CD signal at 222 nm was taken as a measure of the
unfolding of the independent domain with temperature
(Fig. 6, curve 1). A broad sigmoidal transition between
308C and 658C having an apparent Tm of about 488C
was observed for the native dimeric bsSHMT molecule
(Fig. 6, curve 2). This indicates that bsSHMT is a non-
co-operative molecule which starts losing the structure
from very low temperature (308C) and loses most of its
secondary structure at relatively high temperature.
Whereas, PLPbd is stable at temperature up to 458C,
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PLPbd. (A) The curve 1 represents the absorption spectra of
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diagram is showing the spectroscopic changes before (curve 1)
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NaCNBH3. All the spectral measurements for functional
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concentration.
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Fig. 6. Thermal denaturation of recombinant domain and
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of unfolding. The curves 1 and 2 represent data for PLP-binding
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the temperature at which native bsSHMT already lost
>40% structure. This is an interesting observation that
coincides with the data in which the intermediate
populated in the GdmCl-induced folding pathway of
bsSHMT was 40% less structured and was characterized
with 60% residual secondary structure (14). On the other
hand, isolated domain shows relatively cooperative
unfolding against increasing temperature with a sigmoi-
dal transition between 458C and 658C having an appar-
ent Tm of about 538C, demonstrating that the major part
of the protein constituted by this domain is relatively
resistant to thermal unfolding. The Tm of the isolated
domain (538C) was found close to that the Tm (548C) of
the 1 M GdmCl stabilized intermediate, characterized in
folding pathway of bsSHMT in Differential Scanning
Calorimetry (14).
The temperature induced unfolding of recombinant
domain in comparison with the thermal unfolding of
bsSHMT (14), suggest that the PLP-binding domain is
the most stable and co-operative unit of the native
molecule.
GdmCl-Induced Unfolding of PLP-Binding Domain—
The conformational stability of proteins can be measured
by equilibrium unfolding studies using protein denatur-
ants like GdmCl. Analysis of the solvent denaturant
curves using denaturants can provide a measure of the
conformational stability of the proteins (28). Structural
characterizations of the partially folded intermediates
stabilized during denaturant-induced folding/unfolding
of the proteins have provided significant inputs on
the forces that stabilize these folded intermediates of
protein.
Figure 7A shows the change in mean residual
ellipticity at 222 nm with increasing concentration of
GdmCl for the bsSHMT and its isolated recombinant
PLP-binding domain. The GdmCl-induced unfolding of
the recombinant domain showed two-state transition
with a slight decrease in the structure for upto 1 M
GdmCl. The transition was observed between 1 and 2 M
GdmCl, and the domain is almost unfolded with 80% loss
of the secondary structure at 2 M GdmCl. The transition
mid point (Cm value) for domain was found to be about
1.4 M which is quite similar to the second transition
(1.44 M) of the biphasic bsSHMT denaturation. The far-
UV CD spectra of the intermediate stabilized at 0.65–1 M
GdmCl possessed about 64% of the native CD spectral
amplitude. On the other hand, the far-UV CD spectra of
1 M GdmCl stabilized intermediate of the bsSHMT and
native isolated domain both shows common and broad
minima at around 220 nm (Fig. 7B, curve 2). Although,
both these spectra presented in Fig. 7B were taken in two
different conditions, their similarity shows that the par-
tially structured intermediate formed in the equilibrium-
unfolding pathway of bsSHMT has similarity with fully
structured and isolated recombinant PLP-binding domain.
The results obtained from the GdmCl-induced unfolding of
dimeric bsSHMT and its recombinant PLP-binding domain
suggest that the intermediate stabilized in the GdmCl-
induced unfolding pathway of dimeric bsSHMT, is the
structured co-factor-binding apodomain with unstructured
residual part of the monomeric chain of bsSHMT molecule.
To further verify this fact and obtain the structured
portion of the intermediate, limited proteolysis of dimeric
bsSHMT incubated with 1.0 M GdmCl, using a-chymo-
trypsin was carried out.
Figure 7C, shows the SDS–PAGE profile of native
and GdmCl incubated bsSHMT on proteolysis with
a-chymotrypsin. For bsSHMT two major protein bands,
corresponding to the native protein (Band I) and other to
B
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Fig. 7. GdmCl-induced equilibrium unfolding of bsSHMT
and its co-factor-binding domain as studied by CD-
spectroscopy. (A) GdmCl-dependent unfolding of bsSHMT
(open circle) and isolated domain (filled circle) monitored at
222 nm. The data are represented as a percentage of ellipticity
at 222 nm taking the value for the native enzyme to be 100%.
(B) The diagram shows comparison of CD spectra of isolated
domain (curve 1) and bsSHMT in its intermediate state at 1 M
GdmCl (curve 2). (C) Picture shows, SDS–PAGE analysis of
bs-SHMT on limited proteolysis with -chymotrypsin. The protein
to protease ratio was 100:1. In the figure the lanes 1–4
represent molecular weight markers, -chymotrypsin treated
bsSHMT, -chymotrypsin treated 1.0 M GdmCl stabilized
bsSHMT and equal amount of protease, respectively.
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the proteolysed fragment (Band II) of the bsSHMT along
with several minor, low molecular weight protein bands
were observed on treatment of enzyme with a-chymo-
trypsin. The N-terminal sequencing of the band II sug-
gests that it is devoid of 47 amino acid from N-terminal
(22). However, 1 M GdmCl incubated bsSHMT gives a
major band of about 25 kDa on limited proteolytic diges-
tion with a-chymotrypsin. Subsequent, N-terminal
sequence analysis of this proteolysed product indicates
that N-terminus of this band corresponds to amino acid
number 83. This result also suggests that the proteolysis
of intermediate state populated during the unfolding
pathway of bsSHMT at low GdmCl concentration has
major part (about 50%) of the native as structured, which
resists the proteolytic digestion and corresponds to the
major and central domain of the polypeptide chain that is
the PLP-binding domain.
The GdmCl-induced unfolding of isolated domain was
found to be co-operative, where there was no stabilization
of any partially unfolded intermediate. GdmCl probably
denatured the domain directly by solvating the core
of the molecule and unfolded it completely. This
information from the denaturation of isolated recombi-
nant PLP-binding domain can be well correlated with
the unfolding of dimeric bsSHMT, which was dis-
sociated probably because of disturbance in ionic inter-
actions on the dimeric interface and populated with
the partially unstructured and hydrophobic intermedi-
ate (14). Since, it has been already shown that the
populated intermediate has structured PLP-binding
domain (Fig. 7C) along with a residual unstructured
part, it can be said that the intermediate was further
denatured due to the solvation of hydrophobic core of the
domain.
The present study and the previous results (14)
suggests that the PLP-binding domain is the most
stable part of bsSHMT, which attains its tertiary struc-
ture very early in the folding pathway and may acts as a
core of the dimeric bsSHMT (Fig. 8). This observation
has genetic importance because the region which binds
PLP is mostly conserved in the entire aspartate amino-
transferase family and up to some extent in the PLP-
binding proteins (9, 10).
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